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Maternal smoking during pregnancy reduces lung function at birth and 
increases the risk for COPD in adulthood, and even synergizes with personal 
smoking to increase airflow limitation and COPD prevalence in adults. 
Epigenetic mechanisms contribute to COPD pathogenesis, and more 
knowledge regarding epigenetic regulation of a major phenotype within 
COPD (i.e. goblet cell differentiation) would provide novel targets for the 
development of epigenetic–based therapeutic strategies. 
The overall aim of this thesis was to 1) assess the effects and the molecular 
mechanisms of maternal smoking during pregnancy on (smoke-induced) 
lung pathology in an experimental mouse model, 2) examine epigenetic 
mechanisms related to goblet cell differentiation and COPD, and 3) 
establish epigenetic editing as a tool to reduce mucus production. 
Chapter 2 describes an experimental mouse study in which the effect of 
prenatal smoke exposure on airway epithelial cell development and 
underlying molecular mechanisms in neonatal offspring was investigated. 
Maternal smoking during pregnancy disturbed the mucociliary epithelium 
development in the neonatal offspring as it inhibited the ciliated cell 
numbers and expression of the major cilia-related transcription factor Foxj1. 
Our finding thus helps explaining the higher prevalence of fetal and 
childhood respiratory infections in case of maternal smoking. In addition, 
prenatal smoke exposed neonates had an increased expression of 
transcription factors Spdef and Foxm1 which are involved in secretory cell 
differentiation, even though no goblet cells were present yet in the 
neonatal lung, explaining enhanced susceptibility for goblet cell metaplasia 
later in life. Moreover, our data on increased expression of the Notch target 
gene Hey1 suggest that Notch signaling, balancer of the ciliated and 
secretory cell fates in developing airways may be disturbed by the prenatal 
smoke exposure. 
In Chapter 3 we continued our studies in this mouse model and asked 
whether adult offspring from mothers exposed to cigarette smoke during 
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pregnancy were more susceptible to (smoke-induced) inflammation and 
tissue remodeling in the lung. Changes in lung pathology were linked to 
expression of genes that are important in inflammation, xenobiotic 
metabolism, the antioxidant defense system, aging and senescence and 
genes that are related to tissue repair. This question was addressed in a 
mouse model in which maternal smoking during pregnancy (prenatal smoke 
exposure) was combined with postnatal smoke exposure in adult offspring. 
Interestingly, prenatal smoke exposure was found to down regulate smooth 
muscle thickening and affect gene expression related to inflammation, 
oxidative stress and repair. Expression of the anti-inflammatory gene Ahr, 
the anti-oxidant gene Foxo3 and the anti-aging gene Sirt1 were all down 
regulated in prenatal smoke exposed offspring, whereas the airway basal 
cell-related genes Krt5 and Trp63 were increased. Postnatal offspring 
smoking promoted tissue remodeling (more smooth muscle thickening and 
higher expression of Muc5ac), inflammation (M2 dominant macrophages) 
and higher gene expression of Ahrr, Cyp1a1 and Krt5. Prenatal smoke 
exposure did not further deteriorate smoke-induced changes except for 
Krt5 expression, for which less up regulation was found in offspring that 
was born from a smoke-exposed mother. This could implicate that 
endogenous repair mechanisms after injury are less effective when 
prenatally smoke exposed. 
Chapter 4 describes the expression and methylation dynamics of SPDEF and 
FOXA2 in an in vitro model (ALI culture) of airway epithelial cell 
differentiation using PBECs from individuals with COPD and controls. In 
control subjects, expression of SPDEF, together with MUC5AC and AGR2, 
was increased whereas FOXA2 expression was decreased as expected 
during IL-13-induced goblet cell differentiation. This was associated with 
hypermethylation of CpG #8 in the SPDEF promoter whereas no 
methylation changes in the FOXA2 promoter were found. In patients with 
COPD, expression of SPDEF, AGR2, and MUC5AC, as well as methylation of 
SPDEF demonstrated the same trends during IL-13-induced goblet cell 
differentiation as in controls, except for the expression and DNA 




control was addressed in ALI- derived culture without the presence of IL-13. 
Interestingly, higher expression of MUC5AC, AGR2 and SPDEF were found in 
COPD-derived ALI cultures when compared to controls, which was 
associated with hypomethylation of the SPDEF promoter. FOXA2 expression 
was not different between COPD-derived ALI cultures and controls, even 
though COPD-derived ALI cultures displayed hypomethylation in the FOXA2 
promoter. These findings indicate that in COPD, goblet cell differentiation 
and mucus-related gene expression is aberrant and related to a change in 
DNA methylation levels of SPDEF and FOXA2. This aberrant DNA 
methylation might underlie the mucus hypersecretion in COPD, providing 
novel targets in the development of epigenetic-based anti-mucus 
therapeutic strategies. 
Chapter 5 describes a promising epigenetic-based approach for inhibiting 
the mucus production using SPDEF as target. In this in vitro study, four zinc 
finger proteins were engineered to target the SPDEF promoter, and then 
fused to different effector domains (SKD, DNMT3A or G9a). The fusion 
proteins were transduced to A549 cells which highly express MUC5AC and 
SPDEF. All fusion proteins were found to be able to effectively suppress 
both SPDEF mRNA and protein expression, and ZFs-DNMT3A induced de 
novo DNA methylation at the SPDEF promoter. Importantly, all approaches 
were accompanied by inhibition of downstream mucus-related genes AGR2 
and MUC5AC expression. These findings open avenues for epigenetic 
editing as a novel therapeutic strategy to induce, potentially long-lasting, 
mucus inhibition. 
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General discussion 
Smoke exposure effect on airway epithelial cell differentiation 
Smoke exposure effect on ciliated cells 
The ciliated cells of the airway epithelium play a critical role in proper 
mucociliary clearance of inhaled particles and pathogens. In previous 
studies, decrease of ciliated cell numbers, shortened airway cilia and a 
decreased ciliary beat frequency have been linked with impaired 
mucociliary clearance in smokers [1-3]. In chapter 2, we found decreased 
numbers of the ciliated cell and decreased expression of the major cilia-
related transcription factor Foxj1 in prenatal smoke exposed neonates, 
which might explain the increased infant and childhood hospitalization for 
respiratory infections [4,5]. In a recent mouse study of COPD, 9-12 months 
smoke exposure resulted in a total loss of cilia and ciliated cells in the 
trachea [3]. It is not certain however, whether our finding related to 
decreased presence of ciliated cells has the same underlying mechanism as 
the findings of loss of cilia and ciliated cells after chronic smoke exposure. 
In the COPD mouse study, reduction of ciliated cells seemed to be 
accompanied by an additional total loss of secretory cells, leaving only basal 
epithelial cells lining the interior of the trachea. In our model however, 
double staining of cells for CC10 and tubulin showed only a few epithelial 
cells negative for both markers (see also Figure 3 from Chapter 2). In 
addition, mRNA expression of basal cell markers Trp63 or Krt5 showed no 
difference between both groups but presence of KRT5 positive cells still 
needs to be confirmed by IHC.  
Our data do support two recent in vitro studies in which PBECs were 
exposed to cigarette smoke extract (CSE) during differentiation at ALI [6,7]. 
Both of these studies showed CSE-mediated reduction of ciliated cell 
numbers and induction of basal cells (KRT14), even though these two 
studies show contrasting results regarding to secretory cells (as will be 
further discussed later). This suggests that cigarette smoke can alter the 




differentiation. Besides that, Brekman et al. showed a broad CSE-mediated 
suppression of genes involved in ciliary biology, including transcription 
factors FOXJ1, regulatory factor X2 (RFX2), RFX3 and their targets genes. In 
our study, lower numbers of ciliated cells were accompanied by lower 
expression of Foxj1. Ciliated cell differentiation and ciliogenesis is a complex 
process in which a large network of genes, necessary for cilia assembly or 
function is involved. FOXJ1 and RFX family of transcription factors have 
been shown to be important players in controlling ciliary gene expression 
[8]. FOXJ1 regulates genes involved in cilia motility and the apical transport 
of basal bodies, whereas RFX proteins regulate genes involved in 
intraflagellar transport and in basal body anchoring. Both transcription 
factors share some common target genes involved in cilia motility. 
Overexpression of FOXJ1 was shown to be able to prevent CSE-mediated 
cilia shortening but did not prevent CSE-mediated decrease in ciliated cell 
number [6], indicating a potential therapeutic target, only in the early 
stage.  
It is of note that the cytological and functional alteration caused by the 
cigarette smoking might be not permanent which could be covered by the 
continuous regeneration of the respiratory epithelium when the irritating 
stimulus of cigarette smoking is removed [9]. In our mouse model described 
in Chapter 3, prenatal smoke exposure in combination with 12 weeks 
postnatal smoke exposure had no effect on either expression of Foxj1 or 
ciliated cell numbers (data not shown). This might suggest that the airway 
epithelium has recovered from the earlier observed prenatal smoke 
exposure-induced inhibition in ciliated cell development during postnatal 
lung development, and that 12 weeks of postnatal smoke exposure might 
not be enough to severely damage the epithelium as shown after 6-12 
months of smoke exposure [3]. In chapter 4, we found no difference for 
FOXJ1 expression in COPD- and control- derived ALI- cultures in a small set 
of experiments. 
Notch signaling has been reported to promote secretory cell development 
over ciliary cell fate [10,11]. In chapter 2, we show that prenatal exposure 
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to cigarette smoke up regulates Hey1 expression. Hey1 is a Notch target 
gene which implies active Notch signaling in offspring from smoke-exposed 
mothers. Down regulation of Notch downstream effector genes was shown 
in small airway epithelium of smokers and even more down regulation in 
smokers with COPD support our finding [12]. Therefore, active Notch 
signaling could have contributed to the lower ciliated cell development and 
increased expression of goblet cell gene markers. 
 
Smoke exposure effect on Club (Clara) cells and goblet cells 
In chapter 2, no changes were found with respect to the number of Club 
cells and gene expression of Scgb1a1 (Cc10) in prenatal smoke-exposed 
neonatal mice, whereas increased expression of transcription factors 
involved in secretory cell differentiation Spdef and Foxm1 were found, even 
though goblet cells were not present yet in the neonatal lung. In chapter 3, 
we showed increased expression of Muc5ac in postnatal smoke exposed 
mice, which is in agreement of a higher risk for chronic mucus 
hypersecretion in smokers [13]. However, no PAS positive goblet cells were 
observed and gene expression of Scgb1a1 was not changed (data not 
shown). Our data are in agreement with an interesting study from Adair-
Kirk et al [14] who found no difference in the number of Club cells and 
ciliated cells after 6 months of CS exposure but did find an upregulation of 
the Cyp1b1 gene in Club cells due to smoking. This assigns the Club cell to 
be important in the detoxification of CS. In contrast to our results, a 
reduction in Club cell numbers has been found in smoke-exposed rats [15], 
prenatal smoke-exposed mice (secondhand smoke) [16], and also in vitro 
CSE-mediated ALI cultures [6], whereas another in vitro CSE-mediated ALI 
cultures showed increased numbers of Club cells and goblets cells [7]. The 
discrepancies between our study and others regarding smoke exposure 
induced Club cell number changes might reflect species-specific differences, 





 Future perspectives 
The studies presented in this thesis leave us with some questions but also 
suggest several possibilities for future research. 
Sex and gender differences in COPD 
There has been a rapid increase in the numbers of female patients with 
COPD over the past 20 years [17]. Despite the fact of the increasing 
numbers of female smokers, the gender difference in the susceptibility to 
the effect of cigarette smoke is still a topic for debate. Multiple studies have 
shown that female smokers have a faster annual decline in lung function 
(FEV1% predicted) than male smokers [18,19], whereas females also show a 
quicker recovery from lung function decline when they quitted smoking 
[19]. In addition, females were shown to have a lower lung function and 
more severe disease in the group of patients with COPD with low smoking 
exposure or early-onset of disease [20]. Also, in the majority of patients 
(around 70%) with severe COPD, early-onset COPD was seen in females 
[21,22] even though females had markedly fewer pack-years of smoke 
exposure [23]. The differential susceptibility to cigarette smoke in females 
and males could be explained by the hormonally mediated differences in 
cigarette-smoke metabolism or by the fact that females have smaller lungs 
and airways than males [24]. Recently a mouse model of COPD showed that 
chronic smoke exposure increased small airway remodeling in female 
compared with male mice, and that this effect was prevented by 
ovariectomy or selective estrogen antagonism with tamoxifen, providing 
evidence that estrogen may be involved in the dysregulation of the 
oxidant/TGFβ-signaling axis that is unique in smoke-exposed female mice 
[25].  
In our (maternal) smoke mouse model (chapter 3), we found sex 
differences for multiple parameters in the response to smoke exposure, 
which varied from a response in only one sex, an opposite effect in both 
sexes or a stronger effect in one sex than in the other. For Muc5ac 
expression, a postnatal smoke effects was only found in males (Figure 1a), 
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whereas the number of neutrophils only increased in females in pre- and 
postnatal smoke exposed offspring (Figure 1b). In addition, Ahr gene 
expression in males was down regulated due to smoke exposure, whereas 
Ahr gene expression was up regulated in females (Figure 1c). Finally, the 
smoke effect on Cyp1a1 gene expression was much larger in females then 
in males (Figure 1d).  
 
Figure 1 Different (prenatally) smoke-exposure effects on expression of Muc5ac, 
Ahr, Cyp1a1 and number of neutrophils in male and female mice. Expression of (a) 
Muc5ac, (c) Ahrr, and (d) Cyp1a1 was analyzed by quantitative Real Time-PCR in 
RNA, isolated from lung tissue. (b) Scores of Neutrophils (GR1) in lung tissue. Data 
represent medians of expression or cell numbers. NSM: air-exposed mother, SM: 
Smoke-exposed mother. The “Offspring smoke effect” was obtained from a linear 
regression analysis and indicates a difference between both Air-exposed groups 
versus both Smoke-exposed groups. The “Maternal smoke effect”, obtained from a 
linear regression analysis, indicates a difference between both NSM-exposed groups 
versus both SM groups. (A) Negative interaction maternal smoke and offspring 
smoke p=0.017 from linear regression analyses indicates that the offspring smoke 






As can be found in the Estrogen Responsive Genes Database (ERGDB) and 
Androgen Responsive Gene Database (ARGDB), putative estrogen response 
elements are shown in the promoter sequence of different genes, including 
Cyp1a1, Cyp1b1, Trp63, Foxj1, and Scgb1a1, whereas there are also some 
potential androgen responsive genes in our study such as Krt5, Ahr, and 
Spdef. Altogether it suggests the involvement of hormonally mediated 
differences in multiple biology processes. Recently, smoke was shown to be 
able to affect the expression and activity of estrogen receptor- alpha (ERα) 
[26]. In addition, recent studies have shown that activated AHR induced the 
recruitment of ERα to AHR-regulated genes and that AHR is recruited to 
ERa-regulated genes [27,28], which might also explain the sex difference in 
AHR-related xenobiotics metabolism and lung inflammation [29,30]. 
Further exploration of sex differences and the underlying mechanisms 
would be of high interest and importance. 
 
Cross-talk between transcription factors and DNA methylation 
states – in airway epithelial cell differentiation and COPD 
In chapter 4, we observed variable association between SPDEF mRNA 
expression and DNA methylation of different CpG sites in the SPDEF 
promoter during in vitro airway epithelial cell (AEC) differentiation. First, 
methylation of CpG #8 was increased during the goblet cell differentiation, 
which was positively correlated with SPDEF mRNA expression changes. The 
same trend of SPDEF expression and methylation changes were found 
during IL-13-promoted goblet cell differentiation using cells from five 
patients with COPD and six control subjects. These changes might due to 
goblet cell differentiation but cannot rule out the direct effect of IL-13 
treatment itself, which is supported by a recent study in IL-13 treated AECs 
from asthma patients [31]. This study showed that an altered global DNA 
methylation pattern was induced by 24 hours of IL-13 treatment. 
Interestingly, this IL-13 epigenetic signature was validated in freshly 
isolated AECs from subjects with asthma and associated with asthma 
severity and lung function or eosinophilia, which underlines the importance 
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of IL-13 in allergic asthma [31]. However, from that study it is not known 
whether our genes of interest were affected. We speculate that NKX2-1 is a 
transcriptional inhibitor of SPDEF and the NKX2-1 inhibition of the SPDEF 
promoter activity might be impaired by DNA methylation of CpG #8 where 
putative NKX2-1 binding sites are located. For now, there is no direct 
evidence showing that SPDEF is a target gene of NKX2-1 except for their 
inverse role in goblet cell differentiation and mucus production. It would be 
interesting to further investigate the relation of NKX2-1 binding and SPDEF 
promoter methylation (particularly for CpG #8) to SPDEF promoter activity, 
using Chromatin Immunoprecipitation assays and the SPDEF promoter-
driven luciferace assay, combined with Site-directed Mutagenesis, in vitro 
DNA Methylation and in vitro NKX2-1 overexpression in the future. Second, 
hypomethylation of CpG #6 was shown in the COPD-derived ALI-cultures 
(14 days) compared to the control-derived ALI-cultures, which was negative 
associated with SPDEF mRNA expression changes. This observation is 
consistent with the classically repressive role of DNA methylation in the 
regulation of transcription. However, as the results came from a small 
number of patients with COPD versus controls, this finding warrants 
replication in another set of patients with COPD. It is also interesting to 
examine whether the differential SPDEF expression and methylation of CpG 
#6 is smoke-related or COPD-disease specific. To answer this question, cells 
from healthy nonsmokers, healthy smokers and COPD smokers should be 
tested in the future. Another important question to be addressed is 
whether SPDEF expression and methylation are related to mucus 
hypersecretion or lung function (as a biomarker). For this, (airway 
epithelium brushings/ biopsies or sputum) from COPD patients with or 
without chronic mucus secretion should be compared.  
In the study described in chapter 4, we also observed differential FOXA2 
methylation in COPD-derived ALI-cultures compared to control-derived ALI-
cultures, whereas transcriptional expression was not changed. Again, for 
this, we need validation of our data in another replication set of patients. 
Because the changes of FOXA2 methylation were quite small (max 4%), the 




a small increase of goblet cell numbers. Using purely isolated population of 
goblet cells, Club cells and ciliated cells might help to dissect this question. 
It is also necessary to investigate whether the methylation changes are 
smoke-dependent, because FOXA2 expression was shown to be decreased 
in the airway epithelium of healthy smokers and smokers with COPD 
compared to nonsmokers [32]. The correlation between FOXA2 and SPDEF 
is also interesting and there is no direct evidence yet, although evidence 
exists on mutually inhibition of each other [33]. Furthermore, putative 
binding sites of FOXA2/1 locate in the SPDEF promoter and putative binding 
sites of SPDEF exist in the promoter and first exon of FOXA2. All of this 
allows us to speculate that SPDEF and FOXA2 can directly regulate each 
other, and could form a feedback loop in goblet cell differentiation and 
mucus production.  
 
Gene targeted epigenetic reprogramming in the treatment of 
asthma and COPD 
In chapter 2, we found that prenatal smoke exposure induced Spdef 
expression in the lung of neonates. Furthermore, in chapter 4, we found 
that increased SPDEF expression was associated with increased MUC5AC 
expression during goblet cell differentiation as well as in COPD-derived ALI-
culture when compared to controls. This was accompanied with differential 
methylation changes in the SPDEF promoter. As SPDEF is a known key 
transcription factor required for airway goblet cell differentiation and 
mucus production in mice and in human primary airway epithelial cells in 
vitro [33], SPDEF is a potential therapeutic target for anti-mucus 
production. In Chapter 5 we applied the novel approach of epigenetic 
editing, in which programmable Zinc Finger (ZF) DNA binding proteins were 
constructed to target various effectors (DNA methyltransferase 3A 
(DNMT3A), histone 3 lysine 9 (H3K9) methyltransferase G9a and the 
transcription repressor Super KRAB Domain (SKD)) to the promoter 
sequences of SPDEF. Using this new approach we were able to 
downregulate MUC5AC mRNA and protein expression in human alveolar 
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epithelial cell line A549 cells. In addition, we induced DNA methylation on 
the SPDEF promoter, which bears the potential to maintain the SPDEF 
silencing and mucus inhibition. So, as next steps we are going to investigate 
the sustainability effect of ZF-DNMT3A on the SPDEF silencing and mucus 
inhibition using transient expression of ZF-DNMT3A, compared with 
catalytic mutant of ZF-DNMT3A, and ZF-SKD. Previous studies have shown 
that long-term stable repression of the tumor suppressor gene MASPIN and 
oncogene SOX2 could be achieved by ZF targeted DNMT3A in breast cancer 
cells even after the ZF-DNMT3A was not expressed anymore, which proves 
that targeted DNA methylation is a hit-and run strategy for long-lasting 
epigenetic reprogramming gene expression and cell state [34,35]. However, 
another recent study showed that DNA methylation or H3K9 methylation 
targeted into the VEGF-A promoter was not stably propagated after the loss 
of expression of the ZF targeted DNA and H3K9 methyltransferases [36]. 
One possible explanation of the discrepancy between these studies is the 
chromatin context of the tested loci. This means that the choice of 
epigenetic editor for long-term silencing is dependent on the target gene 
and the target cell type. With respect to this issue, the next question is to 
address whether the SPDEF silencing and the MUC5AC inhibition effect 
driven by the ZF-effectors is reproducible in other model systems, because 
A549 is a human alveolar epithelial cell line which might present a 
chromatin context different from our ultimate target: bronchial epithelial 
cells from human individuals with mucus hypersecretion. To best mimic our 
target cells, we continued our experiments in primary bronchial epithelial 
cells (PBECs). For this pilot study (Figure 2a), PBECs from one donor were 
seeded into the transwell inserts in hormone/growth factor–deprived 
medium (Bronchial Epithelial Cell Growth Medium, BEGM) together with 
lentiviral delivered ZF-SKD treatment for two days. Then medium was 
replaced with BEGM containing puromycin to enrich the positively 
transduced cells for five days. Next, cells were cultured in normal BEGM 
until cells reached confluence to create ALI and subsequently they were 
allowed to differentiate in normal BEGM with IL-13 (1 ng/ml) for 21 days. 




transcription and lower numbers of MUC5AC positive cells (Figure 2b-d). 
However, our next attempt using another three donors treated with ZF-
DNMT3A and ZF-G9a was not successful because of too few cells that were 
left after puromycin treatment, making it impossible for the cells to reach 
confluence. Two possible explanations are (1) the existence of a donor-
specific sensitivity for puromycin, and (2) the size of ZF-DNMT3A and ZF-
G9a constructs might be too large for efficient lentiviral transduction, 
leading to less positively transduced cells left in the latter experiment. 
Improvement of the viral titers would increase the transduction efficiency.  
 
Figure 2 SPDEF-targeted silencing by artificial transcription factors (ATFs) in 
primary bronchial epithelial cells (PBECs). a) Schematic representations of the 
experimental model. PBECs from one donor were seeded into the transwell inserts 
in BEGM medium together with lentiviral delivered ZF-SKD treatment for two days 
and then cells were refreshed with BEGM medium. Four days after the cell were 
seeded, cells were cultured with BEGM with puromycin to enrich the positively 
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transduced cells for five days. Next, cells were cultured in normal BEGM until cells 
reached confluence to create ALI and subsequently they were allowed to 
differentiate in normal BEGM with 1 ng/ml IL-13 for 21 days. Cells were harvested 
for RNA, and morphology analysis. mRNA expression of SPDEF (b) was analysed by 
real-time quantitative PCR. Representative images of immunocytochemistry 
staining on MUC5AC (red) at ALI day 21 for empty vector (c) and SKD-SPDEF4 (d) 
treated cells.  
 
Regarding the delivery approach for future experiments, adeno-associated 
virus (AAV) or adenovirus based delivery would be a better choice than 
lentiviral based delivery used in this thesis. First, AAVs or adenoviruses do 
not require hazardous viral DNA/RNA integration into the host DNA [37] 
which makes it safer for gene therapy and clinical use, as supported by the 
recent approval of the first, and the only one till now, gene therapy drug for 
lipoprotein lipase deficiency treatment (AAV based) [38]. Second, for the 
basic biological studies, these viruses cannot propagate in the host cells and 
are degraded after some time [39], which makes it feasible to follow the 
dynamics of the establishment and loss of the epigenetic marks and to 
investigate the sustainability of the epigenetic editing approach. Next to the 
viral delivery, the direct delivery of the targeted Epigenetic-Effectors as 
proteins [40] or chemically modified mRNA [41] also proved to be quite 
promising. Further step into the in vivo pulmonary delivery, mucolytic 
nanoparticles will be proper vehicle for the delivery of gene constructs into 
bronchial epithelial cells after nanoparticle inhalation by aerosolization.  
With respect to the gene specificity of the targeting platform, engineered 
zinc finger binding was shown, by us and by others, to be wide spread for 
several ZF-constructs [42]. The novel target platform transcription 
activator-like effectors (TALEs) and the clustered regularly interspaced short 
palindromic repeats (CRISPRs)-dCas9 complex (where the nuclease activity 
of Cas is mutated to result in a dead Cas9 (dCas)) were shown to have a 
higher specificity [43-45]. The CRISPR-dCas9 system is particularly suitable 
to high-throughput screens because its targeting is based on a cheap and 
flexible system where a single guide RNA pairs with one strand of its target 




origin and may demonstrate less immunogenicity in clinical application than 
TALE and CRISPR/ Cas9 system (of bacterial origin). Indeed, several ZF-
constructs are currently tested in clinical trials for genome editing 
applications. 
In conclusion, in this thesis we have shown that prenatal smoke exposure 
inhibited ciliated cell development and increases expression of secretory 
cell differentiation related transcription factors Spdef and Foxm1 in 
newborns’ lung. In adult mice however, prenatal smoke exposure affected  
mostly other gene expression pathways such as pathways related to 
oxidative stress, aging xenobiotic metabolism, aging and lung repair. 
Postnatal smoke effects on inflammation, remodeling and xenobiotic 
metabolism seemed hardly affected by prenatal smoke exposure effects. 
Regarding our in vitro experiments, in cultured primary cells of patients 
with COPD, DNA hypomethylation and increased expression of SPDEF were 
associated with increased expression of MUC5AC in airway epithelial cells. 
Targeted silencing of SPDEF using Zinc Finger proteins directed DNA and 
histone methyltransferase was able to induce the inhibition of both 
MUC5AC mRNA and protein. This opens avenues for modulating expression 
of any desired target gene. Further research however, needs to explore the 
specificity and sustainability of the targeted epigenetic marks, and the 
ultimate goal would be to achieve sustained reprogramming (e.g. mucus 
reduction) in vivo.  
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